<DOC>
	<DOCNO>NCT01065584</DOCNO>
	<brief_summary>In experimental clinical setting show transplant tolerance possible . It suggest regulatory T cell play beneficial role establishment tolerance . Calcineurin inhibitor may inhibit development regulatory T cell . However , influence calcineurin inhibitor marker transplant tolerance study patient undergo liver transplantation . Currently investigator conduct study evaluate safety efficacy calcineurin inhibitor free immunosuppression patient undergo liver transplantation . In study measurement immune function CD4+CD25high-Foxp3+-Il2/CD8+ status also perform . In parallel measurement compare group patient undergo standard immunosuppression include calcineurin inhibitor .</brief_summary>
	<brief_title>An Observational Study Assess Effect Calcineurin Inhibitors Markers Transplant Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Patients undergo primary liver transplantation Patients age 18 year old Female patient childbearing potential willing perform highly effective contraception study 12 week conclusion study participation Multiple organ graft recipient Patients receive ABO incompatible graft Patients positive cross match Pregnancy Patients psychological , familial , sociologic geographic condition potentially hamper compliance study protocol followup schedule Patients guardianship ( e.g . individual able freely give informed consent )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>liver transplantation</keyword>
	<keyword>Patients undergo liver transplantation</keyword>
</DOC>